strategies to ensure profit maximization; Amarin’s strategic
direction and actions management has taken to stabilize our U.S.
business and position Amarin for growth and value creation; the
runway for growth as Amarin’s strategic focus shifts toward
expanding the business in Europe and other international markets;
potential for positive pricing and successful reimbursement
decisions in Europe; objectives of Amarin’s cost reduction program
and other cash preservation initiatives, and diversification;
Amarin’s commitment to identifying and rigorously evaluating new
highly qualified, independent candidates for Amarin’s Board of
Directors, including full, comprehensive evaluation of Sarissa
Capital Management LP’s proposed nominees; and the overall
potential and future success of VASCEPA (marketed as VAZKEPA in
Europe) and Amarin generally. These forward-looking statements are
not promises or guarantees and involve substantial risks and
uncertainties. A further list and description of these risks,
uncertainties and other risks associated with an investment in
Amarin can be found in Amarin’s filings with the U.S. Securities
and Exchange Commission, including Amarin’s annual report on Form
10-K for the full year
ended 2021, and Amarin’s quarterly reports on Form 10-Q for the quarters ended
March 31, 2022, June 30, 2022, and September 30,
2022, and its other filings. Existing and prospective investors are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date they are made. Amarin
undertakes no obligation to update or revise the information
contained in its forward-looking statements, whether as a result of
new information, future events or circumstances or otherwise.
Amarin’s forward-looking statements do not reflect the potential
impact of significant transactions the company may enter into, such
as mergers, acquisitions, dispositions, joint ventures or any
material agreements that Amarin may enter into, amend or
terminate.
Availability of Other Information About Amarin
Amarin communicates with its investors and the public using the
company website (www.amarincorp.com) and the investor relations
website (investor.amarincorp.com), including but not limited to
investor presentations and FAQs, Securities and Exchange Commission
filings, press releases, public conference calls and webcasts. The
information that Amarin posts on these channels and websites could
be deemed to be material information. As a result, Amarin
encourages investors, the media and others interested in Amarin to
review the information that is posted on these channels, including
the investor relations website, on a regular basis. This list of
channels may be updated from time to time on Amarin’s investor
relations website and may include social media channels. The
contents of Amarin’s website or these channels, or any other
website that may be accessed from its website or these channels,
shall not be deemed incorporated by reference in any filing under
the Securities Act of 1933.
Additional Information
Amarin, its directors and certain of its executive officers may be
deemed to be participants in the solicitation of proxies from
shareholders in connection with the matters to be considered at any
special meeting called at the request of Sarissa. In response to
Sarissa’s requisition notice dated January 10, 2023, the
Company intends to file a definitive proxy statement and WHITE
proxy card with the U.S. Securities and Exchange Commission (the
“SEC”) in connection with any such solicitation of proxies from
shareholders. SHAREHOLDERS ARE STRONGLY ENCOURAGED TO READ ANY SUCH
PROXY STATEMENT AND ACCOMPANYING WHITE PROXY CARD WHEN THEY BECOME
AVAILABLE AS THEY WOULD CONTAIN IMPORTANT INFORMATION. Information
regarding the ownership of the Company’s directors and executive
officers in Company stock and other securities is included in their
SEC filings on Forms 3, 4, and 5, which can be found through the
Company’s website (www.amarincorp.com) in the section “Investors”
or through the SEC’s website at www.sec.gov. Additional information
about Amarin’s directors and executive officers and their interests
is set forth in Amarin’s Annual Report on Form 10-K for the fiscal year ended
December 31, 2021, which was filed with the SEC on
March 1, 2022, and amended on May 2, 2022, as well as
Amarin’s proxy statement for its 2022 Annual General Meeting of
Shareholders, which was filed with the SEC on May 24, 2022,
and in the Company’s other SEC filings, which can be found through
the Company’s website (www.amarincorp.com) in the section
“Investors” or through the SEC’s website at www.sec.gov. More
detailed and updated information regarding the identity of
potential participants, and their direct or indirect interests, by
security holdings or otherwise, would be set forth in the proxy
statement and other materials filed with the SEC in connection with
any special meeting convened at the request of Sarissa.
Shareholders would be able to obtain any proxy statement, any
amendments or supplements to the proxy statement and other
documents filed by the Company with the SEC for no charge at the
SEC’s website at www.sec.gov. Copies will also be available at no
charge at the Company’s website at www.amarincorp.com.